Glycosaminoglycan-degrading enzymes in the varicose vein wall

International Angiology

Volumn 27, Issue 6, 2008, Pages 529-535

  Kowalewski, R ^a   Sobolewski, K ^a   Malkowski, A ^a   Gacko, M ^a   Rutkowska, I ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Glycosaminoglycans; Glycoside hydrolases; Sulphatases; Thrombophlebitis; Varicose veins

Indexed keywords

ARYLOSULFATASE; BETA N ACETYLHEXOSAMINIDASE; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; ENDOGLYCOSIDASE; EXOGLYCOSIDASE; GLYCOSAMINOGLYCAN; GLYCOSIDASE; HEPARAN SULFATE; HYALURONIC ACID; LEVO IDURONIDASE; MATRIX METALLOPROTEINASE; SULFATASE; UNCLASSIFIED DRUG; CHONDROITIN SULFATE; N ACETYLGALACTOSAMINE 4 SULFATASE;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; THROMBOPHLEBITIS; VARICOSIS; VASCULAR SMOOTH MUSCLE; VEIN WALL; ENZYMOLOGY; METABOLISM; SAPHENOUS VEIN; VARICOSE VEINS;

ADULT; BETA-N-ACETYLHEXOSAMINIDASES; CHONDROITIN SULFATES; COLORIMETRY; DERMATAN SULFATE; FEMALE; GLYCOSAMINOGLYCANS; GLYCOSIDE HYDROLASES; HEPARITIN SULFATE; HUMANS; HYALURONIC ACID; IDURONIDASE; MALE; N-ACETYLGALACTOSAMINE-4-SULFATASE; SAPHENOUS VEIN; SULFATASES; THROMBOPHLEBITIS; VARICOSE VEINS;

EID: 60549089540     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Guex JJ, Myon E, Didier L, Nguyen Le C, Taieb C. Chronic venous disease: health status of a population and care impact on this health status through quality of life questionnaires. Int Angiol 2005;24:258-64.
2. Kaplan RM, Criqui MH, Denenberg JO, Bergan J, Fronek A. Quality of life in patients with chronic venous disease: San Diego population study. J Vasc Surg 2003;37:1047-53.
3. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005;15:175-84.
4. Labropoulos N, Leon L, Engelhorn CA, Amaral SI, Rodriguez H, Kang SS et al. Sapheno-femoral junction reflux in patients with a normal saphenous trunk. Eur J Vasc Endovasc Surg 2004;28:595-9.
5. Golledge J, Quigley FG. Pathogenesis of varicose veins. Eur J Vasc Endovasc Surg 2003;25:319-24.
6. Bosman FT, Stamenkovic I. Functional structure and composition of the extracellular matrix. J Pathol 2003;200:423-8.
7. Kockx MM, Knaapen MW, Bortier HE, Cromheeke KM. Boutherin-Falson O, Finnet M. Vascular remodeling in varicose veins. Angiology 1998;49:871-7.
8. Sansilvestri-Morel P, Rupin A, Badier-Commander C, Fabiani JN, Verbeuren TJ. Chronic venous insufficiency: dysregulation of collagen synthesis. Angiology 2003;54 Suppl 1:S13-8.
9. Jeanneret C, Baldi T, Hailemariam S, Koella C, Gewaltig J, Biedermann BC. Selective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography. Br J Surg 2007;94:449-56.
10. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci 2002;115:2817-28.
11. Scott JE. Proteoglycan-fibrillar collagen interactions. Biochem J 1988;252:313-23.
12. Drubaix I, Robert L, Maraval M, Robert AM. Synthesis of glycoconjugates by human diseased veins: modulation by procyanidolic oligomers. Int J Exp Pathol 1997;78:117-21.
13. Wolanska M, Sobolewski K, Glowinski S, Kowalewski R, Plonski A. Glycosaminoglycans of normal veins and their alterations in varicose veins and varicose veins complicated by thrombophlebitis. Eur Surg Res 2001;33:28-32.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
15. Wolanska M, Sobolewski K, Cechowska-Pasko M, Jaworski S. The activities of some glycosaminoglycan-degrading enzymes in uterine leiomyomas. Eur J Obstet Gynecol Reprod Biol 2003;110:73-8.
16. Kowalewski R, Sobolewski K, Malkowski A, Wolanska M, Gacko M. Evaluation of enzymes involved in proteoglycan degradation in the wall of abdominal aortic aneurysms. J Vasc Res 2006;43:95-100.
17. Raman R, Sasisekharan V, Sasisekharan R. Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem Biol 2005;12:267-77.
18. Gillespie DL, Patel A, Fileta B, Chang A, Barnes S, Flagg A et al. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. J Surg Res 2002;106:233-8.
19. Kowalewski R, Sobolewski K, Wolanska M, Gacko M. Matrix metalloproteinases in the vein wall. Int Angiol 2004;23:164-9.
20. Olsson U, Ostergren-Lunden G, Moses J. Glycosaminoglycan-lipoprotein interaction. Glycoconj J 2001;18:789-97.
21. Leta GC, Mourao PA, Tovar AM. Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins. Biochim Biophys Acta 2002;1586:243-53.
22. Badier-Commander C, Couvelard A, Henin D, Verbeuren T, Michel JB, Jacob MP. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 2001;193:398-407.
23. Bingley JA, Hayward IP, Campbell GR, Campbell JH. Relationship of glycosaminoglycan and matrix changes to vascular smooth muscle cell phenotype modulation in rabbit arteries after acute injury. J Vasc Surg 2001;33:155-64.
24. Knudson CB, Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993;7:1233-41.
25. Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 2003;13:612-20.
26. Trowbridge JM, Gallo RL. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 2002;12:117R-25R.